Latest filing published 29 Jun 2016 for Cartesian Therapeutics, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +42.0%Entry US$419.70 · Close at T+365 US$595.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Osage University Partners II, L.P.: trading record in brief
This profile gathers the share dealings of Osage University Partners II, L.P. in Cartesian Therapeutics, Inc. We count 2 filings, every one of them for a trade on 27 June 2016.
Every open-market trade on record is a purchase: 1 purchase worth €4.4M, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
On 29 June 2016 came the latest disclosure, a transaction in Cartesian Therapeutics, Inc. The most recent open-market purchase was published on 29 June 2016, 3,785 days ago. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Osage University Partners II, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 441,628 shares0Common StockSEC:0001104659-16-130148:0
- 350,000 shares@ US$14.00100.0% of flowCommon StockSEC:0001104659-16-130148:1Canonical exit: 25 Sept 2016 (T+90)
2 of 2 declarations
